Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Clario
Best for
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
What to consider
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Phase II-III sponsors that want a specialist eCOA vendor with site and patient helpdesk support
What to consider
Kayentis is an eCOA specialist with 280+ trials in 85 countries and 120 languages, and its Clin'form app runs on BYOD, provisioned devices, web and interview mode. It does not publish build timelines, approval counts or prices.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Clario vs Kayentis (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Clario
Kayentis
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Clario
Supported
Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.
Validated libraries and science services are documented; managed licensing is not established.
Kayentis
Extended support
Questionnaire library and translation tools built with linguistic validation agencies; licensing and validation handled with language-service partners.
The questionnaire library is paired with licensing and validation handled by language-service partners.
Regulatory compliance and track recordFeature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Clario
Supported
States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.
BYOD and provisioned capture are offered with wearable connections.
Time to launch and self-service buildFeature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Clario
Supported
eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.